GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pressure Biosciences PBIO · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 6 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Pressure Biosciences — daily PBIO Delayed
Market value
$8,194
Last close × shares
Volume
2.6k
Shares, 6 Nov 2026

About Pressure Biosciences

Its shares trade under the ticker PBIO. It has been listed since 31 October 1996. In the fiscal year to 31 December 2023, it reported revenue of $2.0m and a net loss of $29.3m. At that date it held total assets of $1.0m and shareholders' equity of −$32.8m.

Pressure BioSciences, Inc. engages in the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables. The company is headquartered in South Easton, Massachusetts. The firm's solutions are based on the properties of both constant and alternating, pressure cycling technology (PCT) hydrostatic pressure. Its PCT is an enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to reproducibly control bio-molecular interactions. Its primary focus is the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications. Its products include Barocyclers, Barocycler Accessories, External Pressure Calibration Device Kit, MicroTubes for Barocyclers, BaroShear K45, HUB High Pressure Generators and Accessories, HP Cell From ISS, and RF1700 Mini Ultra-High Pressure Pump.

Figures and description from our data supplier, not checked against the company's own report.

More about Pressure Biosciences →

Latest on Pressure Biosciences

Our reporting

We have not reported on Pressure Biosciences yet.

Next results

24 Nov 2026

Due on 24 Nov 2026.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Pressure Biosciences's ticker?

Pressure Biosciences trades as PBIO on its US listing, under ISIN US74112E2081.

What was Pressure Biosciences's last closing price?

0.00 on 6 Nov 2026. The figure is in USD and is never converted.

When does Pressure Biosciences next report results?

Results are expected on 24 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.